Zobrazeno 1 - 10
of 89
pro vyhledávání: '"S H, Ralston"'
Publikováno v:
Hauser, B, Raterman, H, Ralston, S H & Lems, W F 2022, ' The Effect of Anti-rheumatic Drugs on the Skeleton ', Calcified Tissue International, vol. 111, no. 5, pp. 445-456 . https://doi.org/10.1007/s00223-022-01001-y
The therapeutic armamentarium for rheumatoid arthritis has increased substantially over the last 20 years. Historically antirheumatic treatment was started late in the disease course and frequently included prolonged high-dose glucocorticoid treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::782edf3b8d168898c767405175ac6abc
https://research.vumc.nl/en/publications/ac2656b0-aa17-419b-b31a-ba580a841015
https://research.vumc.nl/en/publications/ac2656b0-aa17-419b-b31a-ba580a841015
Supplemental material for Cognitive function, disease burden and the structural connectome in systemic lupus erythematosus by S J Wiseman, M E Bastin, E N Amft, J F F Belch, S H Ralston and J M Wardlaw in Lupus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::797504331f4f48d01d79845603574e3f
Autor:
H Behnam-Voshani, S H Ralston, S R Mirhafez, D. Bregman, Anwar A. Jarrad, A Movahedi, M J Niebauer, J K Li, J Wang, J. B. Sack, M. B. Kesselbrenner, T F Li, C F Babbs
Publikováno v:
retten!. 6:78-79
Autor:
Nigel Alexander Morrison, S. H. Ralston, Alexandre S. Stephens, Geoffrey C. Nicholson, James D. Doecke, Richard L. Prince, P. N. Sambrook, Motomi Osato
Publikováno v:
Journal of Bone and Mineral Research. 22:s2-s51
The RUNX2 transcription factor is essential for osteoblast differentiation and chondrocyte maturation. Rare mutations within RUNXZ cause the dominantly inherited skeletal disorder cleidocranial dysplasia which is charaterized by gross dysgenesis of t
Publikováno v:
Journal of Bone and Mineral Research. 5:983-988
Cytokines, such as interleukin-1 (IL-1) and tumor necrosis factors (TNF), produced by cells of the monocyte-macrophage lineage in the local bone microenvironment, are potentially important local regulators of bone turnover. To investigate whether the
Autor:
D. H. Barlow, P. Bouchard, M. L. Brandi, J. L. Evers, A. Glasier, E. Negri, S. E. Papapoulos, S. H. Ralston, R. Rizzoli, D. T. Baird, J. Collins, G. Benagiano, P.G. Crosignani, C. La Vecchia, A. Volpe, P. G. Crosignani
Publikováno v:
Barlow, D H, Bouchard, P, Brandi, M L, Evers, J L H, Glasier, A, Negri, E, Papapoulos, S E, Ralston, S H, Rizzoli, R, Baird, D T, Collins, J, Benagiano, G, Crosignani, P G, La Vecchia, C, Volpe, A 2010, ' Bone fractures after menopause ', Human Reproduction Update, vol. 16, no. 6, pp. 761-773 . https://doi.org/10.1093/humupd/dmq008
Human Reproduction Update, 16(6), 761-773. Oxford University Press
Human Reproduction Update
Human Reproduction Update, 16(6), 761-773. Oxford University Press
Human Reproduction Update
Background: Every year 30% of individuals above age 65 fall, and falls are the principal cause of bone fractures. To reduce fracture incidence requires both prevention of falls and maintenance of bone strength. Methods: PubMed searches were performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff2cad5bcf1ba65ad555dd811ebf7c0
http://hdl.handle.net/11585/868074
http://hdl.handle.net/11585/868074
Publikováno v:
The Journal of Immunology. 159:5132-5142
The production of large amounts of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) has been described as a double-edged sword eliciting pro- or anti-inflammatory effects in different immune situations. Our aim, therefore, was to investiga
Autor:
S. H. Ralston, R. J. vanʼt Hof
Publikováno v:
Current Opinion in Orthopaedics. 8:19-24
Autor:
Jean-Jacques Body, D. Thiébaud, H. Hagberg, Beat Thürlimann, J. Walls, M. Tubiana-Hulin, R. Rizzoll, Zuzana Herrmann, S. H. Ralston, M. R. Lichinitser, H. J. Huss, E. U. Steinhauer
Publikováno v:
British Journal of Cancer
Hypercalcaemia is an important cause of morbidity in malignant disease. We studied the efficacy and safety of intravenous ibandronate (a new, potent bisphosphonate) in a multicentre study of 147 patients with severe cancer-associated hypercalcaemia w
Publikováno v:
Journal of Clinical Oncology. 13:2427-2430
PURPOSE To study the effects of oral clodronate on bone pain in patients with advanced metastatic bone disease. PATIENTS AND METHODS Fifty-five patients with progressing bone metastases were randomized to receive oral clodronate 1,600 mg/d (n = 27) o